Aspen Aerogels price target lowered to $20 from $28 at Canaccord

Canaccord lowered the firm’s price target on Aspen Aerogels (ASPN) to $20 from $28 and keeps a Buy rating on the shares. The firm adjusted its model to capture some of the uncertainties ahead yet values it a premium to peers based on its strong growth potential beyond 2027 through its numerous OEM relationships, competitive moat, strong balance sheet, and potential for healthy FCF generation.